Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05530408 · ClinicalTrials.gov registry record
Quantitative Pulmonary Imaging Registry & Biorepository
A clinical trial of Pulmonary Disease, sponsored by University of Kansas Medical Center.
- Recruiting
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT05530408 is a study of Pulmonary Disease that is actively recruiting participants, run by University of Kansas Medical Center. The registered enrollment target is 100 participants, below the 620-participant average among 19 other Pulmonary Disease trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05530408, a study of Pulmonary Disease, is actively recruiting participants, sponsored by University of Kansas Medical Center.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed toward identifying clinical applications of imaging methods and toward understanding the physiological significance of imaging biomarkers. This registry and biorepository will accelerate the development of these imaging techniques and may lead toward future clinical adoption of quantitative pulmonary imaging.
Conditions Studied
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-05-24 |
| Est. Completion | 2028-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05530408
The ClinicalTrials.gov registry entry for NCT05530408 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 620-participant average among 19 other Pulmonary Disease trials with a reported enrollment target (84% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pulmonary Disease appearing as the primary indexed condition, and to 0 interventions.
NCT05530408 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT05530408 about?
NCT05530408 is a clinical study titled "Quantitative Pulmonary Imaging Registry & Biorepository". The goal of this project is to establish a registry and biorepository of images and biological samples from subjects undergoing novel pulmonary imaging methods to be used for future research aimed toward identifying clinical applications of imaging methods and toward understanding the physiological ...
What is the current status of trial NCT05530408?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2022-05-24. Estimated completion is 2028-05-31.
What conditions does trial NCT05530408 study?
This clinical trial studies the following conditions: Pulmonary Disease.
Who is sponsoring clinical trial NCT05530408?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05530408 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exhaled Breath: A Novel Technique for Rapid Diagnosis of Respiratory Diseases and Infections
RECRUITING
-
Merck IIT: RRP Pembro and Lenvatinib
RECRUITING · Early Phase 1
-
Study of Lung Proteins in Patients With Pneumonia
RECRUITING
-
Natural History Study of Biomarkers in Pulmonary Arterial Hypertension
RECRUITING
-
Risk Underlying Rural Areas Longitudinal Cohort Study (RURAL) Heart and Lung Study
RECRUITING
-
Cooperative Assessment of Late Effects for SCD Curative Therapies
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.